Back
Avista Corp. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Sell
37
AVA
Avista Corp.
Last Price:
$38.59
Seasonality Move:
5.24%
Buy
87
KYMR
Kymera Therapeutics, Inc.
Last Price:
$89.98
Seasonality Move:
7.7%
Sell
37
Avista Corp. (AVA)
is a Sell
Is Avista Corp. a Buy, Sell or Hold?
-
The current Avista Corp. [AVA] share price is $38.44. The Score for AVA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
AVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $86.88. The Score for KYMR is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
AVA Stock Price Chart
What is Avista Corp.'s stock price today?
-
The Avista Corp. share price today is $38.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVA is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $86.88Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
AVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 36.13 | Sell |
| Chaikin Money Flow: | -125007 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.97 | Buy |
| Relative Strength Index (14 RSI): | 72.81 | Buy |
| Chaikin Money Flow: | -897315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.35 | Sell |
| 20-day SMA: | 40.45 | Sell |
| 50-day SMA: | 39.19 | Sell |
| 200-day SMA: | 38.7 | Sell |
| 8-day EMA: | 39.18 | Sell |
| 20-day EMA: | 39.75 | Sell |
| 50-day EMA: | 39.3 | Sell |
| 200-day EMA: | 38.37 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.38 | Buy |
| 20-day SMA: | 67.89 | Buy |
| 50-day SMA: | 62.54 | Buy |
| 200-day SMA: | 44.51 | Buy |
| 8-day EMA: | 75.59 | Buy |
| 20-day EMA: | 69.41 | Buy |
| 50-day EMA: | 62.91 | Buy |
| 200-day EMA: | 49.79 | Buy |
Avista Corp. Earnings Growth & AVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and an increase next year of $0.25 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.35 per share.
Avista Corp. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||